Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-06-05

FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for albuterol sulfate by Sandoz Inc under NDA 020503, signaling an approved modification to the existing product authori…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albuterol sulfate (Albuterol sulfate)

Snippet

SUPPL AP for ALBUTEROL SULFATE (ALBUTEROL SULFATE)